Pharma < Article List - KBR

Samsung Biologics bolsters quality and regulatory affairs with 2 leadership appointments
Marianne Chang 2023.08.24 11:34
Sam Chun Dang Pharm licenses out Eylea biosimilar to Canadian company in $15 mil. deal
Marianne Chang 2023.08.24 10:59
Ildong Pharmaceutical enters Chinese API market for hypertension treatment
Lee Han-soo 2023.08.23 16:51
SK bioscience says cell-cultured influenza vaccine will become new norm
Lee Han-soo 2023.08.23 16:00
HLB subsidiary Verismo secures CD-19 binder to target blood cancers
Marianne Chang 2023.08.23 15:36
Korea's healthcare exports suffer 18.2% dip in H1
Marianne Chang 2023.08.23 14:09
Celltrion scores partial approval for phase 3 IND plan for multiple sclerosis biosimilar in Europe
Marianne Chang 2023.08.22 16:39
GC questions safety of hemophilia A drug Hemlibra sold by JW Pharmaceutical
Kim Chan-hyuk 2023.08.22 15:07
HK inno.N's NSCLC drug picked for national drug development project
Lee Han-soo 2023.08.21 16:16
Genome&Company aims to license out 2 anti-cancer candidates by 2023
Marianne Chang 2023.08.21 14:35
JW Shinyak to resume marketing of SK bioscience’s flu vaccine
Lee Han-soo 2023.08.21 13:34
Hanmi begins clinical trial of dual antibody immunotherapy BH3120
Kim Chan-hyuk 2023.08.21 13:24